Concepedia

Hengyu Wu

HW

Statistics

Publications

11

Citations

387

H-Index

10

Active since

2016

Affiliations

Third Hospital of Nanchang(Current)

Ludwig-Maximilians-Universität München

Nanchang University

Second Affiliated Hospital of Zhejiang University

Zhejiang University

Hengyu Wu is an author at Third Hospital of Nanchang specializing in oncology, medicine, and molecular oncology.

Publications per year

2016–2024

11

Publications

11

Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis

Yanchun Li, Jun Xia, Fangchun Shao et al. · Biochemical and Biophysical Research Communications · 2020 · 167 citations

Life Sciences, Cancer Biology, Cell Biology +17

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets

Fangteng Liu, Hengyu Wu · Journal of Inflammation Research · 2021 · 45 citations · Full text

Medicine, Immunology, Oncology +17

Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction

Fangchun Shao, Yanchun Li, Wanye Hu et al. · Frontiers in Oncology · 2021 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +11

YTHDF2-mediated regulations bifurcate BHPF-induced programmed cell deaths

Jiebo Lin, Guankai Zhan, Jinfeng Liu et al. · National Science Review · 2023 · 33 citations · Full text

Life Sciences, Molecular Biology, Toxicology +9

NDC80 promotes proliferation and metastasis of colon cancer cells

Xuekun Xing, Hengyu Wu, Hong-liu Chen et al. · Genetics and Molecular Research · 2016 · 26 citations · Full text

Medicine, Cell Biology, Oncology +16

1–5 of 11